BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1829836)

  • 1. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
    Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and genomic configuration of GM-CSF, IL-3, M-CSF receptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes.
    Mareni C; Sessarego M; Montera M; Fugazza G; Origone P; D'Amato E; Lerza R; Pistoia V; Scarra GB
    Leuk Lymphoma; 1994 Sep; 15(1-2):135-41. PubMed ID: 7858491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
    Boultwood J; Fidler C; Lewis S; MacCarthy A; Sheridan H; Kelly S; Oscier D; Buckle VJ; Wainscoat JS
    Blood; 1993 Nov; 82(9):2611-6. PubMed ID: 8219215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q.
    Le Beau MM; Epstein ND; O'Brien SJ; Nienhuis AW; Yang YC; Clark SC; Rowley JD
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5913-7. PubMed ID: 3497400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
    Jaju RJ; Boultwood J; Oliver FJ; Kostrzewa M; Fidler C; Parker N; McPherson JD; Morris SW; Müller U; Wainscoat JS; Kearney L
    Genes Chromosomes Cancer; 1998 Jul; 22(3):251-6. PubMed ID: 9624537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome].
    Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H
    Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 5q- breakpoint in an acute nonlymphocytic leukemia patient using pulsed-field gel electrophoresis.
    Thornton DE; Theil K; Payson R; Balcerzak SP; Chiu IM
    Am J Med Genet; 1991 Dec; 41(4):557-65. PubMed ID: 1723247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
    Sun Y; Cook JR
    Leuk Res; 2010 Mar; 34(3):340-3. PubMed ID: 19608274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).
    Le Beau MM; Lemons RS; Espinosa R; Larson RA; Arai N; Rowley JD
    Blood; 1989 Feb; 73(3):647-50. PubMed ID: 2783863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
    Lewis S; Oscier D; Boultwood J; Ross F; Fitchett M; Rack K; Abrahamson G; Buckle V; Wainscoat JS
    Am J Hematol; 1995 Jul; 49(3):194-200. PubMed ID: 7604812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune-thrombocytopenia and SLE in a patient with 5q-anomaly and deletion of the c-fms oncogene.
    Jaeger U; Panzer S; Bartram C; Haas O; Volc-Platzer B; Graninger W; Geissler K; Radaszkiewicz T; Lechner K
    Am J Hematol; 1994 Jan; 45(1):79-80. PubMed ID: 8250012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum.
    Washington LT; Doherty D; Glassman A; Martins J; Ibrahim S; Lai R
    Leuk Lymphoma; 2002 Apr; 43(4):761-5. PubMed ID: 12153162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemia.
    Shepherd L; Cameron C; Galbraith P; Windsor S; Lillicrap D
    Leuk Res; 1991; 15(5):297-303. PubMed ID: 1675299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
    Pettenati MJ; Le Beau MM; Lemons RS; Shima EA; Kawasaki ES; Larson RA; Sherr CJ; Diaz MO; Rowley JD
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2970-4. PubMed ID: 3495006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoidosis in a patient with 5q-myelodysplasia. A possible pathogenetic link between the two diseases.
    Airaghi L; Montori D; Zorzi F; Miadonna A; Tedeschi A
    Monaldi Arch Chest Dis; 2000 Oct; 55(5):378-80. PubMed ID: 11213374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.